Azabicyclooctane derivatives as FXR agonists for use in the treatment of liver and gastrointestinal diseases

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Badman, Michael,Klickstein, Lloyd B.,Laffitte, Bryan

申请号：

AU2015365481

公开号：

AU2015365481A1

申请日:

2015.12.08

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using compounds of Formula (I) or (II). In particular, the invention provides for the use of compounds of Formula (I) or (II), or a stereoisomer, enantionmer or pharmaceutically acceptable salt thereof, for treating or preventing liver and gastrointestinal diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/